Stay updated on Sasanlimab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.

Latest updates to the Sasanlimab in Advanced Malignancies Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedLocations section updated: new site entries added (Beijing Municipality, Chongqing Municipality, Jiangsu, Shanghai Municipality, Tokyo, Pesochny, Sankt-Peterburg, Stavropol Kray, Yaroslavl Oblast, Gyeonggi-do, Kyiv Oblast, Kyivska Oblast, Sumska Oblast) and several previously listed locations removed. Page revision updated to v3.3.3.SummaryDifference1%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedMinor textual updates: PubMed publications are automatically filled from PubMed, and the revision history now notes v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe government funding status notice about NIH operations has been removed from the page. This change does not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check68 days agoChange DetectedNo significant additions or deletions were detected between the two screenshots; the page content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check90 days agoChange DetectedUpdate announces version v3.2.0 and adds a government funding and operating status notice, replacing the previous v3.1.0.SummaryDifference2%

- Check97 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

Stay in the know with updates to Sasanlimab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.